share_log

天津发展(00882.HK):力生制药2023年度净利润增286.54%至3.62亿元

Tianjin Development (00882.HK): Lisheng Pharmaceuticals' net profit increased by 286.54% to 362 million yuan in 2023

Gelonghui Finance ·  Mar 21 18:35

Gelonghui, March 22丨Tianjin Development (00882.HK) announced that in 2023, Lisheng Pharmaceutical (002393.SZ) achieved operating income of RMB 1.153 billion, up 0.56% year on year; net profit attributable to shareholders of listed companies was 362 million yuan, up 286.54% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 149.6 million yuan, up 20.26% year on year; basic earnings per share were 1.97 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment